These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8201547)

  • 1. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
    Yomota C; Miyazaki T; Okada S
    Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].
    Miyazaki T; Komuro T; Yomota C; Okada S
    Eisei Shikenjo Hokoku; 1990; (108):95-7. PubMed ID: 1364368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function.
    Takeuchi H; Yasuji T; Yamamoto H; Kawashima Y
    Pharm Res; 2000 Jan; 17(1):94-9. PubMed ID: 10714615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the influencing factors on the drug release from sodium alginate matrices].
    Nie SF; Wu XM; Liu HF; Jiang HW; Pan WS
    Yao Xue Xue Bao; 2004 Jul; 39(7):561-5. PubMed ID: 15493851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery.
    Miyazaki S; Nakayama A; Oda M; Takada M; Attwood D
    Biol Pharm Bull; 1994 May; 17(5):745-7. PubMed ID: 7920448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures.
    Moroni A; Drefko W; Thone G
    Drug Dev Ind Pharm; 2011 Feb; 37(2):216-24. PubMed ID: 20973612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and in vitro evaluation of a film-controlled dosage form self-converted from monolithic tablet in gastrointestinal environment.
    Zhang T; Mao S; Sun W
    J Pharm Sci; 2010 Nov; 99(11):4678-90. PubMed ID: 20845465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan and sodium alginate-based bioadhesive vaginal tablets.
    El-Kamel A; Sokar M; Naggar V; Al Gamal S
    AAPS PharmSci; 2002; 4(4):E44. PubMed ID: 12646014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of insulin in chitosan-coated alginate beads: oral therapeutic peptide delivery.
    Onal S; Zihnioğlu F
    Artif Cells Blood Substit Immobil Biotechnol; 2002 May; 30(3):229-37. PubMed ID: 12066877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate/chitosan particulate systems for sodium diclofenac release.
    González-Rodríguez ML; Holgado MA; Sánchez-Lafuente C; Rabasco AM; Fini A
    Int J Pharm; 2002 Jan; 232(1-2):225-34. PubMed ID: 11790506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency.
    Takka S; Acartürk F
    J Microencapsul; 1999; 16(3):275-90. PubMed ID: 10340214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
    Nie SF; Liu H; Liu YL; Pan WS
    Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
    Alsarra IA; El-Bagory I; Bayomi MA
    Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
    Bayomi MA; Al-Suwayeh SA; El-Helw AR
    Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of in-vitro release and bioavailability of sustained release diclofenac sodium from certain hydrophilic polymers and commercial tablets in beagle dogs.
    Hosny EA; al-Helw AR; al-Dardiri MA
    Pharm Acta Helv; 1997 Jun; 72(3):159-64. PubMed ID: 9204774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads.
    Sezer AD; Akbuğa J
    J Microencapsul; 1999; 16(2):195-203. PubMed ID: 10080113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution studies on tablets of ibuprofen using chitosan.
    Ilango R; Kavimani S; Jaykar B; Umamaheshwari G
    Indian J Exp Biol; 1999 May; 37(5):505-8. PubMed ID: 10492622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads.
    Aburahma MH; Hamza Yel-S
    Pharm Dev Technol; 2011 Aug; 16(4):316-30. PubMed ID: 20307250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.